The AIDS pandemic continues to present us with unique scientific and public health
challenges. Although the development of effective antiretroviral therapy has been a major …

Monoclonal antibodies (mAbs) are increasingly being considered as agents to fight severe
viral diseases. So far, they have essentially been selected and used on the basis of their …

Maternal HIV-1–specific antibodies are efficiently transferred to newborns, but their role in
disease control is unknown. We administered neutralizing IgG, including the human …

Early initiation of antiretroviral therapy (ART) alters viral rebound kinetics after analytic
treatment interruption (ATI) and may play a role in promoting HIV-1 remission. Autologous …

Novel broadly neutralizing antibodies targeting HIV-1 hold promise for their use in the
prevention and treatment of HIV-1 infection. Pre-clinical results have encouraged the …

Background:'Elite controllers' are rare HIV-infected individuals who are able to
spontaneously control HIV replication without medication, maintaining viral loads that are …

Anti-HIV broadly neutralizing antibodies (bNAbs) may favor development of antiviral
immunity by engaging the immune system during immunotherapy. Targeting integrin α4β7 …

A combination of advances spanning from isolation to delivery of potent HIV-specific
antibodies has begun to revolutionize understandings of antibody-mediated antiviral activity …

HIV-1 bNAbs can enhance adaptive host immune responses in PLWH. The challenge now
is to exploit these immunomodulatory properties to design optimized therapeutic …

Vaccinal effect of HIV-1 antibody therapy : Current Opinion in HIV and AIDS Vaccinal effect of
HIV-1 antibody therapy : Current Opinion in HIV and AIDS Log in or Register Subscribe to …